Concepedia

Jessica Furst

JF

Statistics

Publications

5

Citations

657

H-Index

5

Active since

2007

Affiliations

NewYork–Presbyterian Hospital(Current)

Cornell University

New York Hospital Queens

Lymphoma Research Foundation

Jessica Furst is an author at NewYork–Presbyterian Hospital specializing in pharmacotherapy, pharmacology, and thrombosis.

Top concepts

Publications per year

2007–2016

5

Publications

5

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes

Jessica Furst, Leonardo Bandeira, Wen-Wei Fan et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 210 citations · Full text

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 182 citations · Full text

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

Tomer M. Mark, Jessica Stern, Jessica Furst et al. · Biology of Blood and Marrow Transplantation · 2008 · 115 citations · Full text

Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy

Rubén Niesvizky, Tara Naib, Paul J. Christos et al. · British Journal of Haematology · 2007 · 89 citations · Full text

Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma

Rubén Niesvizky, Déborah Martı́nez-Baños, Jessica Jalbrzikowski et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 61 citations

, , +13

1–5 of 5